Literature DB >> 10959940

Additional information from parental questionnaires and pharmacy records for registration of birth defects. EuroMAP-group.

J Reefhuis1, H E de Walle, L T de Jong-van den Berg, M C Cornel.   

Abstract

EUROCAT Northern Netherlands registers children born with a birth defect in the Northern Netherlands. Data used to be collected via a notification form, which is filled out by the notifier and, if necessary, completed by the general practitioner. To increase the amount of information, EUROCAT started using new methodology in July 1997. The new procedure consists of three additional steps. Firstly, a parental questionnaire with 43 questions concerning pregnancy and medical history is sent to the parents. Also, the pharmacist is approached to provide information on the drugs that were dispensed to the mother in the period from three months before until the end of the pregnancy. The last step is a telephone interview with the mother. In this study the old and new method are compared with respect to response, quality and quantity of the data. Of the 198 parental questionnaires included in this study, 179 (90.4%) were returned. The pharmacists returned 173 out of 179 requests for information (96.6%). The parental information is more complete for ethnicity and serum screening. The quality of the drug exposure data is much better using the new methodology. The general practitioner's input is still necessary for specification and verification of the diagnosis.

Entities:  

Mesh:

Year:  2000        PMID: 10959940     DOI: 10.1023/a:1007656619529

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  5 in total

1.  Drug use in pregnancy: a comparative appraisal of data collecting methods.

Authors:  L T de Jong-van den Berg; C M Waardenburg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

2.  Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group.

Authors:  L T De Jong van den Berg; N Feenstra; H T Sorensen; M C Cornel
Journal:  Teratology       Date:  1999-07

3.  Population-based birth-defect and risk-factor surveillance: data from the Northern Netherlands.

Authors:  M C Cornel; J D Erickson; M J Khoury; L M James; Y Liu
Journal:  Int J Risk Saf Med       Date:  1996

4.  Malformation surveillance and maternal drug exposure: the MADRE project.

Authors:  E Robert; S E Vollset; L Botto; P A Lancaster; P Merlob; P Mastroiacovo; G Cocchi; M Ashizawa; S Sakamoto; I Orioli
Journal:  Int J Risk Saf Med       Date:  1994

5.  Registries of congenital anomalies: EUROCAT.

Authors:  M F Lechat; H Dolk
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

  5 in total
  1 in total

1.  Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands.

Authors:  Marleen M H J van Gelder; Iris A L M van Rooij; Hermien E K de Walle; Nel Roeleveld; Marian K Bakker
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.